How I treat Logo

howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Home

Neurological Problems in Hematology Practice

Seizures

Causes:

  • Idiopathic epilepsy
  • Head injury
  • Congenital cerebral defects
  • Cerebral abscess, meningitis, tuberculoma, encephalitis, cerebral malaria
  • Cavernous sinus thrombosis
  • Febrile convulsions
  • Pyridoxine deficiency
  • Hypoglycemia
  • Hypoxia
  • Intracranial space occupying lesion
  • Acute poisoning
  • Infections
  • Hyponatremia
  • Hypocalcemia
  • Uremia
  • Eclampsia
  • Degenerative brain disease
  • Drugs
  • Posterior reversible encephalopathy syndrome

 

Evaluation:

  • History and examination
  • Blood sugar levels
  • Send: CBC, PT, APTT, RFT, LFT, Electrolytes
  • Drug and alcohol screen
  • ABG
  • Blood culture
  • ECG
  • Chest X Ray
  • CT/MRI of brain

 

Treatment:

  • High dose O2 by face mask
  • Inj. Midazolam- 0.05-0.1mg/kg- IV up to 10mg  /  Inj. Lorazepam- 0.07mg/kg- up to 4 mg- IV
  • If seizures do not stop- Midazolam infusion- 0.05mg/kg/hr
  • Inj. Levetiracetam- 500mg- in 100ml NS- IV- BD

 

Altered Consciousness/ Unconscious Patient

Causes:

  • Severe infection
  • Cerebral malaria
  • Meningitis
  • Encephalitis
  • Cerebral tumor
  • Hypoglycemia
  • Diabetic ketoacidosis
  • Uremia
  • Poisoning- Drugs, Alcohol
  • CCF, MI
  • Severe anemia
  • Cerebrovascular accident
  • Brainstem lesion: tumor, hemorrhage, demyelination
  • Head injury- Concussion, hematoma
  • Hepatic failure
  • Uremic encephalopathy
  • Metabolic acidosis
  • Hyponatremia
  • Hyperosmolarity
  • Hypercalcemia
  • Postepileptic coma
  • Hypertensive encephalopathy
  • Heat stroke
  • Wernicke's encephalopathy
  • Hyper/Hypothyroidism
  • Psychogenic unresponsiveness
  • CO2 Narcosis, Hypoxia

 

Glasgow Coma Scale (E_M_V_)

  • Eye Opening (E)
    • 4- Spontaneous
    • 3- To speech
    • 2- To pain
    • 1- No Response
  • Motor Response (M)
    • 6- Obeys
    • 5- Localizes
    • 4- Withdraws
    • 3- Abnormal flexion
    • 2- Extensor response
    • 1- Nil
  • Verbal Response (V)
    • 5- Oriented
    • 4- Confused conversation
    • 3- Inappropriate words
    • 2- Incomprehensible sounds
    • 1- Nil

 

Evaluation:

  • History and examination
  • Blood glucose using glucometer
  • Hemogram, RFT, LFT, PT, APTT, Electrolytes, S. Lactate, Ammonia, ABG
  • Blood for drug level estimation/ choline esterase
  • Blood culture
  • Malaria by QBC
  • Urine routine
  • Chest X Ray
  • USG abdomen
  • ECG
  • CT/ MRI Brain
  • Lumbar puncture

 

Treatment:

  • 50% Dextrose- 50ml with Thiamine 100mg- over 30min- Give irrespective of cause
  • Treatment of cause
    • Ryle's tube insertion. Stomach wash if poisoning
    • Catheterize bladder
    • Intubation for airway protection
    • Start RT feeds
    • Eye shield and Neosporine ointment- To prevent exposure keratitis
    • Prevent bed sores- 2nd hrly change of position, Nurse on air/water bed
    • Chest physiotherapy
    • Intermittent throat suction to clear secretions/ Care of ET tube, periodic sterile suction

 

Epidural/ Spinal Cord Compression

If identified early patient may be spared of significant disability

 

Causes:

  • Metastatic malignancy, lymphoma, myeloma, sarcoma- most commonly in thoracic spine
  • Tuberculosis, osteomyelitis
  • Epidural hematoma
  • Herniated intervertebral disc

 

Clinical features:

  • Backache
    • Frequently referred/ radicular pain
    • Unlike prolapsed disc, pain is exacerbated by recumbency and is improved by up-right position 
  • Weakness and Sensory impairment
    • Follows within hours to weeks after onset of back pain
    • Begins in proximal legs
    • Can progress to paraplegia
  • Autonomic dysfunction- Bladder, Bowel dysfunction

 

Investigations:

  • Whole spine MRI
  • CT Myelography, if MRI is contraindicated
  • CT or MRI guided biopsy

 

Treatment

  • Immediate hospitalization
  • Analgesics for pain control
  • Inj. Dexamethasone- 8 mg- 6th hrly- Start immediately after the diagnosis is suspected. Do not wait for imaging reports.
  • Immediate neurosurgery consultation for decompression procedure and / or stabilization of spine.
  • Radiation-
    • Either in lieu of surgery or after surgery
    • 10 uninterrupted fractions of 3 Gray each
    • RT must be started within 24hrs of onset of symptoms

 

Methotrexate Induced Encephalopathy

  • Stroke like acute neurotoxicity
  • Often secondary to decreased renal function which leads to decreased elimination of methotrexate
  • Treatment:
    • Inj. Aminophylline- 2.5mg/kg IV infusion over 60min
    • Inj. Folinic acid
  • Usually full recovery is seen

 

Idiopathic Hyperammonemia

  • Seen 2.4% of leukemia treated patients and 1.2% of patients undergoing stem cell transplant.
  • Mortality- 75%
  • Risk factors:
    • Catabolic state
    • Total parenteral nutrition
    • GI hemorrhage
    • Infections
  • Clinical features
    • Progressive encephalopathy
    • Tachypnea
  • Investigations
    • LFT- Normal
    • Respiratory alkalosis due to hyperventilation
    • S. Ammonia levels- >2folds the upper limit of normal and  rising
  • Other causes of encephalopathy have to be excluded- Reye's syndrome, port-systemic shunt, fulminant hepatitis, cirrhosis, veno occlusive disease, hypoglycemia etc
  • Rule out drug induced hyperammonemia- Sodium valproate, L-asparaginase
  • Treatment:
    • Should be started immediately, otherwise irreversible brain damage ensures
    • Stop protein supplementation. Later on 2% solution of essential amino acids (valine, leucine and isoleucine) may be provided.
    • Calories- 100-200kCal/kg/2hrs- With 10% glucose with insulin (1unit/4gm of glucose)
    • Increase ammonia secretion- Arginine, sodium benzoate, sodium phenyl acetate
    • Identify and treat GI bleed
    • Lactulose- 20ml- 6hrly
    • PO- Neomycin- 50-100mg/kg/day
    • Hemodialysis
    • Mechanical ventilation if altered sensorium/ cerebral edema
    • Monitor electrolytes

 

Posterior Reversible Encephalopathy Syndrome and Hypertensive Emergencies

Introduction:

  • It is a condition characterized by variable association of 
    • Seizure activity
    • Consciousness impairment/ confusion/ coma
    •  Headache
    • Visual abnormalities: Blurred vision, visual neglect, homonynoushemianopia, visual hallucinations, cortical blindness
    • Nausea, vomiting
    • Hypertension- Often present

 

Epidemiology:

  • Age: 4-90 years, most cases in young and middle age
  • Marked female predominance

 

Etiology:

  • Toxic agents:
    • Chemotherapy agents: Cisplatin, oxaliplatin, carboplatin, gemcitabine, cytarabine, methotrexate, vincristine, L-asparaginase
    • Anti-angiogenic agents: Bevacizumab, sunitinib, RAF kinase inhibitors
    • Immunomodulatory cytokines: Interferon alpha, IL 2
    • Monoclonal antibodies: Rituximab, Infliximab
    • IV Immunoglobulin
    • Anti TNF alpha- Etanercept
    • Anti lymphocyte globulin
    • Immunosuppressive agents: Cyclosporine, tacrolimus, sirolimus
    • High dose corticosteroids
    • Others- G-CSF, ART, Linezolid, EPO, IV Contrast agents, Carbamazepine
  • Hypertension
  • Infections and sepsis
  • Pre-eclampsia and eclampsia
  • Autoimmune disorders: SLE, PAN, Wagener's granulomatosis, thrombotic micro-angiopathy, systemic sclerosis, Takayasuarteritis, Hashimoto encephalopathy, Crohn disease
  • Others: Sickle cell disease, GBS, Hypomagnesemia, hypercalcemia, tumor lysis syndrome, porphyria, pheochromocytoma, Cushing syndrome

 

Pathogenesis:

2 hypotheses

  • Impaired cerebral autoregulation leading to increased cerebral blood flow. This leads to cerebral edema
  • Endothelial dysfunction with release of proinflammatory cytokines. This causes increased vascular tone and subsequent cerebral hypoperfusion

 

Investigations:

  • MRI combined with MRA:
    • Bilateral symmetric regions of edema typically located in the white matter and predominating posterior parietal and occipital lobes
    • T2 weighted images show areas of high signal intensity
    • Fluid attenuated inversion recovery (FLAIR) also visualize the lesions
    • Other associated abnormalities that can be seen are: cerebral ischemia, hemorrhage, herniation
  • EEG: To be done to look for non convulsive status epilepticus
  • Lumbar puncture and CSF analysis
  • Neurosurgical biopsy: If patient fails to respond to appropriate therapy

 

Differential diagnosis:

  • Ictal/ post-ictal phase
  • Progressive multifocal leuco-encephalopathy
  • CADASIL
  • Infectious encephalitis
  • Acute disseminated encephalomyelitis
  • MELAS
  • Vasculitis
  • Creutzfeldt Jacob disease
  • Cerebral venous sinus thrombosis
  • Ischemic stroke

 

Prognosis:

  • With appropriate treatment there is full recovery. But sometimes permanent complications/ fatalities are observed.

 

Treatment:

  • Admit in ICU, ionotropic support if needed, endotracheal intubation to protect airway
  • Look for hypoglycemia and treat accordingly (Give thiamine along with glucose)
  • Look for hypomagnesemia and treat promptly
  • Antiepileptics: Clonazepam 1mg- Repeat up to 3 times if necessary, followed by Levetiracetam
  • Control of hypertensive emergency
    • Aim should not be to normalize BP but reduce mean arterial pressure by 20-25% within first 2 hrs, then bring down BP to 160/100 mm of Hg within 1st 6 hrs. More rapid reduction promotes ischemia.
    • Inj. Labetalol/ Nicardipine
  • Correction of underlying causes of PRES
    • BP Control
    • Withdrawal of cancer chemotherapy/ immunosuppressant
    • Termination of pregnancy
    • Dialysis

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

Reports

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo

howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.